Taiwan's Academia Sinica said Friday that it has screened out protease inhibitors of the COVID-19 coronavirus, which could eventually lead to the development of targeted drugs to stop the virus from replicating itself in patients' bodies.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
Taiwan shares open lower
11/13/2025 09:20 AM - Business
China Airlines to boost Europe routes, launch KLM codeshare
11/12/2025 10:59 PM - Society
Flooding persists in Hualien's Mingli Village after heavy rain
11/12/2025 10:43 PM - Society
2 Taiwanese men probed over false claims on VP Hsiao's IPAC speech
11/12/2025 10:11 PM - Cross-Strait
President, legislative speaker exchange barbs on China threat to lawmaker
11/12/2025 09:36 PM